367: The ouster of CDC's director, biotech venture firm rankings
The Readout Loud
00:00
Challenges in Biotech Venture Capital and New Investment Metrics
This chapter explores the recent decline in funds raised by biotech venture capital firms and its implications on investment returns. The speakers also highlight new metrics for evaluating VC performance, along with a promotional mention of a detailed VC report.
Transcript
Play full episode
